Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
Appendix, ATM, bankruptcy, Blvd, Boulevard, bradycardia, breach, cap, chord, CMC, COBRA, compelling, concurred, decision, delivering, developmental, edema, enriched, Europe, evidencing, excise, explore, finely, Forest, freely, frozen, Gilenya, Gottlieb, half, indemnification, insulate, invoke, JG, JGA, maker, map, moderate, noteholder, Notwithstanding, oral, orchestrator, overnight, parachute, pecuniary, perspective, pool, pooled, preexisting, preferentially, prepay, proceed, propagated, pulmonary, rationale, reagent, repricing, retrospective, screening, shipped, subordinated, subset, successor, summed, superseded, supplement, taxable, thawed, thereof, tradable, trademark, Treasury, unsecured, VAM, veracity, vision, Visium, waiver, white
Removed:
attacking, baseline, began, black, clarify, communication, contractually, Crescent, cryopreserved, culture, directed, dollar, doubt, enrolled, equivalent, exercising, experienced, explicit, expressed, facilitate, formalized, formulation, harmful, harmonizing, hohlfeld, inclusion, interaction, islet, Japan, Jim, joint, lesion, lynne, monocyte, Multicenter, North, overhead, prohibited, prospect, qualification, randall, reactive, Recently, recording, resolve, retroactively, revising, Ridge, sheath, SPA, subgroup, tech, twelve, twenty, uniform, utilization, variety
Filing tables
Filing exhibits
Related press release
ACER similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statement on Forms S-3 (No. 333-153501 and 333-163108), and Form S-8 (No. 333-139196) pertaining to the Opexa Therapeutics, Inc. June 2004 Compensatory Stock Option Plan, of our report dated March 8, 2011 with respect to the audited financial statements of Opexa Therapeutics, Inc. for the years ended December 31, 2010 and 2009.
/s/ MaloneBailey, LLP |
MaloneBailey, LLP |
www.malone-bailey.com |
Houston, Texas |
March 8, 2011 |